Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [HEALTH]
2 clusters · 2 sources · 11 days · First seen · Last updated
Roche AXELIOS 1 genomic sequencing rollout
Overview
Roche has begun expanding the availability and implementation of its AXELIOS 1 next-generation sequencing platform. Following a global launch, the company introduced the technology to the Asia Pacific region, hosting promotional events in Sydney and Seoul to engage researchers regarding its use in studying complex diseases and genetic diversity.
In Europe, San Raffaele Hospital in Milan has implemented the platform to enhance its genomic capabilities. The technology utilizes expansion sequencing to reduce analysis times, reportedly allowing DNA sequencing that previously took several days to be completed within four hours. Medical professionals at the hospital indicated that the platform’s speed and ability to analyze multiple samples simultaneously will support more personalized therapies and improved diagnosis for complex diseases.
Entities
Axelios 1 · Asia Pacific · San Raffaele Hospital · Milan · Roche Diagnostics
Timeline
-
[HEALTH] 2 sourcesSan Raffaele Hospital installs new genomic sequencing platform
San Raffaele Hospital in Milan has deployed Roche Diagnostics' Axelios 1 platform, reducing DNA sequencing time from days to just four hours to improve personalized medicine.
-
[TECHNOLOGY] 2 sourcesRoche introduces AXELIOS 1 sequencing technology in Asia Pacific
Roche is launching its AXELIOS 1 sequencing technology in the Asia Pacific region to support growing genomic research needs and complex disease studies.
Sources
notizie.it · quotidiano.net